EP0964706A1 - Biomaterialien fur medizinische anwendungen - Google Patents

Biomaterialien fur medizinische anwendungen

Info

Publication number
EP0964706A1
EP0964706A1 EP96933263A EP96933263A EP0964706A1 EP 0964706 A1 EP0964706 A1 EP 0964706A1 EP 96933263 A EP96933263 A EP 96933263A EP 96933263 A EP96933263 A EP 96933263A EP 0964706 A1 EP0964706 A1 EP 0964706A1
Authority
EP
European Patent Office
Prior art keywords
biomaterial
prostheses
triclosan
medical
biomaterials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96933263A
Other languages
English (en)
French (fr)
Other versions
EP0964706A4 (de
Inventor
Paul Kenneth Priscott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0964706A1 publication Critical patent/EP0964706A1/de
Publication of EP0964706A4 publication Critical patent/EP0964706A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Definitions

  • the present invention relates to improvements in biomaterials including ceramics and polymeric materials for use in medical applications, particularly in the use of such polymeric materials in the manufacture of medical devices and prostheses
  • the present invention also relates to the medical devices and prostheses per se comprising such biomaterials
  • prosthetic devices available to modern medicine provide effective relief from a range of painful, crippling and life-threatening disorders. Some, such as, artificial heart valves and haemodialysis shunts, have become essential for the survival of many patients, others, such as, prosthetic joints, enable patients to regain the ability to perform important physical activities. Artificial devices have been successfully developed and incorporated into nearly all of the body systems and the numbers of patients receiving implants continues to increase. There is no doubt that prostheses have both prolonged and improved the quality of life for millions of individuals.
  • a wide variety of organisms are capable of initiating these iatrogenic infections
  • the proportions vary with the type of device and medical procedure, but include Enterobacter spp, Enterococcns spp, Escherichia coli, Klebsiella spp, Pseudomonas aentginosa, Staphylococcus spp, Candida albicans and others Often the organism may arise from the patients own body flora but may also result from the hospital environment or nursing procedures.
  • Triclosan (generic name) is a well-known broad spectrum antimicrobial agent for topical applications in cosmetic applications and for general hygiene applications, such as the antimicrobial applications to inanimate substrates, such as textiles
  • Triclosan (2,4,4 1 -trichloro-2 I -hydroxy diphenyl ether) has the molecular formula C ⁇ 2 H 7 CL 3 O 2 and is commercially available under the trade names Irgasan (Ciba-Geigy Limited) and Microban (Hoechst Celanese). Its physical properties, toxicology and compatibility with various chemicals used in the hygiene area are well documented. Its uses extend from additives to soaps, deodorants and toothpastes to incorporation in textile materials and yarns. It is incorporated into clothing to control the growth of microorganisms between launderings. Other common applications include animal beds, dental floss, shoe innersoles, furniture coverings and public transport seating, to name but a few.
  • a biomaterial comprising an antimicrobial or therapeutically effective amount of Triclosan, when used in the manufacture of a medical device or prosthesis for internal or in vivo medical applications
  • Triclosan is readily available commercially with a purity greater than 99% The compound exhibits marked anti-microbial properties across a wide range of bacteria or fungi, including most of those mentioned above as being causative agents of iatrogenic infections In its usage to date, Triclosan has not induced resistance in exposed organisms The product has been marketed for many years as an anti-microbial system for preserving cosmetics and industrial products, for oral care products such as toothpaste and or hand disinfectants Through these uses it has undergone extensive toxicological testing and been found to be safe at recommended concentrations Additionally, the chemical has good environmental properties, yet is stable to hydrolysis It is poorly soluble in water and highly soluble in may organic solvents
  • Triclosan has not previously been considered to be therapeutic in nature According to the present invention it is proposed that, by appropriate application, the chemical can be used in therapeutic situations in conjunction with therapeutic devices and prostheses. According to the invention, various types of biomaterials, including ceramics and polymers, can be produced incorporating Triclosan that would have distinct advantages over currently available and used materials. This has the potential to provide significant socio-economic benefits to both individuals and communities through decreased likelihood of iatrogenic infections and consequent shorter periods of hospitalisation/treatment.
  • Triclosan is incorporated into the biomaterial by addition of Triclosan during the mixing/polymerisation stage, whereby the Triclosan is colloidally and homogeneously suspended within the amorphous zone of the polymer or other biomaterial.
  • the Triclosan is introduced into the interstitial spaces of the polymer or other biomaterial in such a way as to not effect the physical properties of the biomaterial. These spaces act as reservoir for the Triclosan from which sub-micron sized particles thereof migrate to the surface of the biomaterial on demand There they become a tightly bound durable part ofthe surface itself.
  • the surface of the biomaterial can be engineered to retain antimicrobial and biocompatible for the life ofthe product, and provides continuous, inherent control of the growth of broad range of microorganisms, including gram-positive and gram-negative bacteria, as well as fungi, moulds, mildew and yeasts. Triclosan is also believed to exhibit some virus-inactivating properties which prevent virus replication.
  • Triclosan penetrates and disrupts the metabolic function of thin-walled microorganisms, interrupting their ability to function, grow and reproduce. Normal human cells are thick- walled, and are therefore unaffected by Triclosan.
  • the antimicrobial biomaterials according to the present invention comprise a therapeutically effective amount of Triclosan. The amount used is for the most part arbitrary, depending primarily on the requirements of the particular application and the cost versus effective use life.
  • Triclosan is incorporated into the polymer or other biomaterial in the range of from about 0.5% to about 5% by weight of the biomaterial, depending on the use requirements, but this range may be varied as required
  • the present invention is applicable to any polymeric material or other biomaterial used in medical applications for the manufacture of medical devices or prostheses, including but not limited to polyvinyl chloride (PVC), polyamides, polystyrene, teflon as well as metals and ceramics.
  • PVC polyvinyl chloride
  • the antimicrobial polymeric material can be utilised in. cast, extruded, injection moulded, rotary moulded or blow moulded products, or in products which are machined according to end use requirements
  • the invention is also applicable to durable coatings of biomaterials, such as polymeric coatings, applied to metallic surfaces, as may be required for some prostheses.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
EP96933263A 1995-10-13 1996-10-14 Biomaterialien fur medizinische anwendungen Withdrawn EP0964706A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN5965A AUPN596595A0 (en) 1995-10-13 1995-10-13 Improvements in polymeric materials for use in medical applications
AUPN596595 1995-10-13
PCT/AU1996/000642 WO1997014447A1 (en) 1995-10-13 1996-10-14 Biomaterials for use in medical applications

Publications (2)

Publication Number Publication Date
EP0964706A1 true EP0964706A1 (de) 1999-12-22
EP0964706A4 EP0964706A4 (de) 2000-12-27

Family

ID=3790292

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96933263A Withdrawn EP0964706A4 (de) 1995-10-13 1996-10-14 Biomaterialien fur medizinische anwendungen

Country Status (3)

Country Link
EP (1) EP0964706A4 (de)
AU (1) AUPN596595A0 (de)
WO (1) WO1997014447A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044414A1 (en) * 1999-01-28 2000-08-03 Union Carbide Chemicals & Plastics Technology Corporation Lubricious medical devices
US20020193879A1 (en) * 2001-04-11 2002-12-19 Seder Edmund V. Medical devices having antimicrobial properties
US7393547B2 (en) 2001-04-11 2008-07-01 Helix Medical, Llc Antimicrobial elastomer composition and method for making
US7520897B2 (en) * 2001-04-11 2009-04-21 Helix Medical, Llc Medical devices having antimicrobial properties
US8317861B2 (en) 2001-04-11 2012-11-27 Helix Medical, Llc Antimicrobial indwelling voice prosthesis
US6887270B2 (en) 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US7993390B2 (en) 2002-02-08 2011-08-09 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US6923833B2 (en) 2002-04-09 2005-08-02 Ray C. Wasielewski Biologically reabsorbable acetabular constraining components and materials for use with a hip replacement prosthesis and bioreabsorbable materials to augment hip replacement stability and function
US8920826B2 (en) 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US9597067B2 (en) 2002-10-04 2017-03-21 Ethicon, Inc. Packaged antimicrobial medical device and method of preparing same
US7309361B2 (en) 2002-10-23 2007-12-18 Wasielewski Ray C Biologic modular tibial and femoral component augments for use with total knee arthroplasty
US7901705B2 (en) 2006-02-28 2011-03-08 Tyco Healthcare Group Lp Antimicrobial releasing polymers
US9247973B2 (en) 2007-09-28 2016-02-02 DePuy Synthes Products, Inc. Anti-microbial implant
US9763697B2 (en) 2008-12-16 2017-09-19 DePuy Synthes Products, Inc. Anti-infective spinal rod with surface features
US10245025B2 (en) 2012-04-06 2019-04-02 Ethicon, Inc. Packaged antimicrobial medical device having improved shelf life and method of preparing same
US20190290800A1 (en) 2016-03-17 2019-09-26 Centro Cardiologico Monzino Polymers and uses thereof in manufacturing of 'living' heart valves

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076954T3 (es) * 1988-04-23 1995-11-16 Smith & Nephew Inc Guantes para cirujanos.
WO1990001956A1 (en) * 1988-08-24 1990-03-08 Smith & Nephew Plc Antimicrobial articles, their preparation and use
DE68913549D1 (de) * 1988-09-07 1994-04-07 Smith & Nephew Rohrförmige gegenstände.
US5236699A (en) * 1992-06-22 1993-08-17 Libin Barry M Antiplaque mouth rinse
JPH11500330A (ja) * 1995-01-18 1999-01-12 ヴィタフォア コーポレイション 抗菌性医療装置及び方法

Also Published As

Publication number Publication date
AUPN596595A0 (en) 1995-11-09
EP0964706A4 (de) 2000-12-27
WO1997014447A1 (en) 1997-04-24

Similar Documents

Publication Publication Date Title
US12035718B2 (en) Biofilm penetrating compositions and methods
Romanò et al. Hyaluronic acid and its composites as a local antimicrobial/antiadhesive barrier
EP0964706A1 (de) Biomaterialien fur medizinische anwendungen
Schierholz et al. Efficacy of silver-coated medical devices
Lansdown Effects and Safety in Use
US7238363B2 (en) Modification of medical prostheses
Schierholz et al. Implant infections: a haven for opportunistic bacteria
US7314857B2 (en) Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
US7087661B1 (en) Safe and effective biofilm inhibitory compounds and health-related uses thereof
EP2389071B1 (de) Antimikrobielle zusammensetzung zur biofilmentfernung und ihre verwendung
US9072292B2 (en) Biofilm resistant polymer materials
CN104105500B (zh) 基于牛磺罗定和鱼精蛋白组合的广谱抗微生物组合物以及包含此类组合物的医疗装置
US20080139450A1 (en) Antimicrobial Compositions and Uses Thereof
US20100074932A1 (en) Antimicrobial compositions containing gallium
Mittelman Adhesion to biomaterials
EP0889742A1 (de) Verbesserungen bei der wundbehandlung
JP2010533562A (ja) 滅菌バリヤを備えたフォリイ・カテーテル
WO2002085542A1 (en) Antimicrobial polymeric surfaces
AU712132B2 (en) Improvements in implantable medical devices
US20230149603A1 (en) Drug-releasing polymer composition and device
JP2004532108A (ja) 抗菌性ポリマー表面
AU700866B2 (en) Improvements in wound care management
CN121910000A (zh) 新型高效抗菌组合物

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980504

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE GB

A4 Supplementary search report drawn up and despatched

Effective date: 20001110

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE GB

17Q First examination report despatched

Effective date: 20020617

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021029